Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|9|1|14-36

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.1, 2008-01, pp. : 14-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Aldose Reductase Inhibition on Heart Rate Variability in Patients with Severe or Moderate Diabetic Autonomic Neuropathy

By Didangelos T.P.  

Clinical Drug Investigation, Vol. 15, Iss. 2, 1998-02 ,pp. : 111-121

Adis International

Access to resources Recommend Favorite

Aldose Reductase in Diabetic Microvascular Complications

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 373-385

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose reductase inhibitors: therapeutic implications for diabetic complications

By Oates P.J.   Mylari B.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2095-2119

Informa Healthcare

Access to resources Recommend Favorite

Genetic Analysis of Aldose Reductase in Diabetic Complications

By  

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1375-1387

Bentham Science Publishers

Access to resources Recommend Favorite